Trevi Therapeutics
BioTech/Drugs - New Haven, CT, US
Trevi Therapeutics Employees
Trevi Therapeutics Senior Management
Trevi Therapeutics Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Trevi Therapeutics Technologies
Email Providers
Outlook
SSL Certificates
Media Temple SSL
Other
Mobile Friendly
Hosting
GoDaddy Hosting
Search Marketing
Adobe Marketing Cloud